Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hertenstein

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Der Internist|October 27, 2004
[Bone marrow transplantation. Indications, chances and perspectives]B Hertenstein, A Ganser
Annals of Hematology|April 1, 1996
Allogenic bone marrow transplantation or chemotherapy for patients with acute myeloid leukemia in first complete remission: a decision analysis approachB Hertenstein, G Heil, H Heimpel
Experimental Hematology|August 1, 1984
Natural killer (NK) cells and interferon in Friend-virus-infected susceptible and resistant miceB Hertenstein, L Kreja, H J Seidel
Klinische Monatsblatter Fur Augenheilkunde|June 1, 1987
[Orbital and ocular mucormycosis]E C Pittke, B Hertenstein, R Bachor
Der Internist|March 1, 1996
[Transplantation of hematopoietic stem cells]B Hertenstein, J Novotny, W Ebell, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
A comparative review of methods for T cell depletion in the prophylaxis of graft-versus-host diseaseB Hertenstein, L Arseniev, J Novotny, et al.
Deutsche Medizinische Wochenschrift (1946)|July 20, 1999
[Interventional antimicrobial therapy for febrile complications after high-dose chemotherapy and autologous stem cell transplantation. Standard recommendations of the Work Group of Infections in Hematology and Oncology of the German Association of Hematology and Oncology]G Maschmeyer, B Hertenstein, B Glass, et al.
Bone Marrow Transplantation|November 2, 2004
Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantationA Woywodt, M Haubitz, S Buchholz, et al.
Bone Marrow Transplantation|June 25, 2002
Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantationL Hambach, M Stadler, E Dammann, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1988
Concentration of bone marrow mononuclear cells for in vitro treatment and AB0-incompatible transplantation: a rapid and reproducible procedure using the haemonetics V50 cell separatorM Wiesneth, B Hertenstein, K Koerner, et al.
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Der Internist|October 27, 2004
[Bone marrow transplantation. Indications, chances and perspectives]B Hertenstein, A Ganser
Annals of Hematology|April 1, 1996
Allogenic bone marrow transplantation or chemotherapy for patients with acute myeloid leukemia in first complete remission: a decision analysis approachB Hertenstein, G Heil, H Heimpel
Experimental Hematology|August 1, 1984
Natural killer (NK) cells and interferon in Friend-virus-infected susceptible and resistant miceB Hertenstein, L Kreja, H J Seidel
Klinische Monatsblatter Fur Augenheilkunde|June 1, 1987
[Orbital and ocular mucormycosis]E C Pittke, B Hertenstein, R Bachor
Der Internist|March 1, 1996
[Transplantation of hematopoietic stem cells]B Hertenstein, J Novotny, W Ebell, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 21, 2007
A comparative review of methods for T cell depletion in the prophylaxis of graft-versus-host diseaseB Hertenstein, L Arseniev, J Novotny, et al.
Deutsche Medizinische Wochenschrift (1946)|July 20, 1999
[Interventional antimicrobial therapy for febrile complications after high-dose chemotherapy and autologous stem cell transplantation. Standard recommendations of the Work Group of Infections in Hematology and Oncology of the German Association of Hematology and Oncology]G Maschmeyer, B Hertenstein, B Glass, et al.
Bone Marrow Transplantation|November 2, 2004
Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantationA Woywodt, M Haubitz, S Buchholz, et al.
Bone Marrow Transplantation|June 25, 2002
Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantationL Hambach, M Stadler, E Dammann, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1988
Concentration of bone marrow mononuclear cells for in vitro treatment and AB0-incompatible transplantation: a rapid and reproducible procedure using the haemonetics V50 cell separatorM Wiesneth, B Hertenstein, K Koerner, et al.
Pageof 11